Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-11, Vol.34 (11), p.3042-3046
Hauptverfasser:	Popov, Alexander, Buldini, Barbara, De Lorenzo, Paola, Disarò, Silvia, Verzhbitskaya, Tatiana, Movchan, Liudmila, Giarin, Emanuela, Shorikov, Egor, Di Meglio, Annamaria, Tsaur, Grigory, Parasole, Rosanna, Miakova, Natalia, Boichenko, Elmira, Kondratchik, Konstantin, Aleinikova, Olga, Karachunskiy, Alexander, Roumiantsev, Alexander, Locatelli, Franco, Biondi, Andrea, Pieters, Rob, Valsecchi, Maria Grazia, Fechina, Larisa, Basso, Giuseppe
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 692/308/575 692/699/67/1990/283/2125 Acute lymphoblastic leukemia Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bone Marrow - pathology Cancer Research Critical Care Medicine Cytometry Female Flow Cytometry - methods Hematology Humans Incidence Infant Infants Intensive Internal Medicine Letter Leukemia Lymphatic leukemia Male Medical prognosis Medicine Medicine & Public Health Minimal residual disease Neoplasm, Residual - diagnosis Oncology Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Prognosis Recurrence Survival Analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!